Correlation of serum procalcitonin with the severity of skin and skin structure infections - A pilot study;Korrelation der Procalcitonin-Konzentration im Serum mit dem Schweregrad von Haut- und Weichteilinfektionen

JDDG - Journal of the German Society of Dermatology

Volumn 10, Issue 8, 2012, Pages 564-570

  Eder, Johanna ^a,b   Hlavin, Gerald ^c   Haushofer, Alexander ^b   Trubert Exinger, Doris ^b   Trautinger, Franz ^a,b  

^a Karl Landsteiner Institute of Dermatological Research   (Austria)

^b Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

antibiotics; bacterial infection; biomarkers; procalcitonin; sepsis; skin and skin structure infections

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN;

ABSCESS; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BODY TEMPERATURE; CELLULITIS; CLINICAL ARTICLE; DISEASE SEVERITY; ERYSIPELAS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; PILOT STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SKIN INFECTION; TREATMENT DURATION; ULCER;

AGED; AGED, 80 AND OVER; AUSTRIA; BIOLOGICAL MARKERS; CALCITONIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PREVALENCE; PROTEIN PRECURSORS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, BACTERIAL; SKIN DISEASES, INFECTIOUS; STATISTICS AS TOPIC;

EID: 84864425760     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2011.07858.x     Document Type: Article

References (33)

1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C,. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8. (Pubitemid 23066085)
2. Chesney RW, McCarron DM, Haddad JG, Hawker CD, DiBella FP, Chesney PJ, Davis JP,. Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. J Lab Clin Med 1983; 101: 576-85. (Pubitemid 13119185)
3. Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B,. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 2010; 8: 575-87.
4. Meisner M, Tschaikowsky K, Schnabel S, Schmidt J, Katalinic A, Schuttler J,. Procalcitonin-influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur J Clin Chem Clin Biochem 1997; 35: 597-601. (Pubitemid 27387071)
5. Hatzistilianou M,. Diagnostic and prognostic role of procalcitonin in infections. ScientificWorldJournal 2010; 10: 1941-6.
6. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Muller B,. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006; 174: 84-93. (Pubitemid 43955248)
7. Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, Periat P, Bucher HC, Christ-Crain M,. Procalci-tonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008; 168: 2000-7; discussion 07-8.
8. Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, Angus DC,. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008; 52: 48-58 e2.
9. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY,. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34: 1996-2003. (Pubitemid 43982479)
10. Becker KL, Snider R, Nylen ES,. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008; 36: 941-52.
11. Tang BM, Eslick GD, Craig JC, McLean AS,. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analy-sis. Lancet Infect Dis 2007; 7: 210-7. (Pubitemid 46274517)
12. Reinhart K, Karzai W, Meisner M,. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000; 26: 1193-200.
13. Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, Begue RJ, Piette JC, Aumaitre O,. Can procalcito-nin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003; 62: 337-40. (Pubitemid 36363440)
14. Boussekey N, Leroy O, Georges H, Devos P, d'Escrivan T, Guery B,. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 2005; 33: 257-63. (Pubitemid 41152186)
15. Iapichino G, Marzorati S, Umbrello M, Baccalini R, Barassi A, Cainarca M, Colombo Pavini F, Mantovani E, Mauri A, Moroni B, Noto A, Melzi D'Eril GV, Langer M,. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions? Minerva Anestesiol 2010; 76: 814-23.
16. Karlsson S, Heikkinen M, Pettila V, Alila S, Vaisanen S, Pulkki K, Kolho E, Ruokonen E,. Predictive value of pro-calcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care 2010; 14: R205.
17. Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J,. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008; 177: 498-505. (Pubitemid 351442188)
18. Hochreiter M, Kohler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S,. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 2009; 13: R83.
19. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Regnier B, Brun-Buisson C, Chastre J, Wolff M,. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010; 375: 463-74.
20. Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C, Widmer I, Neidert S, Blum CA, Schonenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Muller B,. Procalcitonin guided antibiotic therapy and hospita-lization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 2007; 7: 102.
21. Mimoz O, Benoist J F, Edouard AR, Assicot M, Bohuon C, Samii K,. Procalci-tonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24: 185-8. (Pubitemid 28190774)
22. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J,. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24: 680-4. (Pubitemid 28393399)
23. Keski-Nisula L, Roponen M, Hirvonen MR, Heinonen S, Pekkanen J,. Stimulated cytokine production correlates in umbilical arterial and venous blood at delivery. Eur Cytokine Netw 2004; 15: 347-52. (Pubitemid 40127660)
24. Carsin H, Assicot M, Feger F, Roy O, Pennacino I, Le Bever H, Ainaud P, Bohuon C,. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endo-toxin levels early after thermal injury. Burns 1997; 23: 218-24. (Pubitemid 27303043)
25. Nylen ES, O'Neill W, Jordan MH, Snider RH, Moore CF, Lewis M, Silva OL, Becker KL,. Serum procalci-tonin as an index of inhalation injury in burns. Horm Metab Res 1992; 24: 439-43.
26. von Heimburg D, Stieghorst W, Khorram-Sefat R, Pallua N,. Procalcitonin -a sepsis parameter in severe burn injuries. Burns 1998; 24: 745-50. (Pubitemid 29022845)
27. Jeandrot A, Richard JL, Combescure C, Jourdan N, Finge S, Rodier M, Corbeau P, Sotto A, Lavigne J P,. Serum procalci-tonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia 2008; 51: 347-52.
28. Schöfer H, Effendy I, Hartmann M, Jappe U, Plettenberg A, Reimann H, Seifert H, Sunderkötter C, Weberschock T, Wichelhaus TA, Nast A,. S2k + IDA Leitlinie: Diagnostik und Therapie Staphylococcus aureus bedingter Infektionen der Haut und Schleimhäute., 2011.
29. Klaus-Friedrich Bodmann,. Empfeh-lungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankun-gen bei Erwachsenen-Update 2010, 2010.
30. Claeys R, Vinken S, Spapen H, ver Elst K, Decochez K, Huyghens L, Gorus FK,. Plasma procalcitonin and C-reac-tive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002; 30: 757-62. (Pubitemid 34297790)
31. Chan YL, Tseng CP, Tsay PK, Chang SS, Chiu TF, Chen JC,. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 2004; 8: R12-20.
32. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J,. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-17. (Pubitemid 38971491)
33. Wilcox MH, Corey GR, Talbot GH, Thye D, Friedland D, Baculik T,. CANVAS 2: the second Phase III, randomized, double-blind study evaluating cef-taroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Che-mother 2010; 65 Suppl 4: iv53-iv65.